Grow Your Pharma Business Digitally
Market Place
Post Enquiry
Company
01 Gowling Lafleur Henderson LLP (1)
02 Gowling WLG (Canada) LLP (6)
Patent
01 2527646 (7)
Product
01 LISDEXAMFETAMINE DIMESYLATE (2)
02 Lisdexamfetamine Dimesylate (5)
Dosage
01 CAPSULE (2)
02 Capsule (5)
Exp Date
01 2024-01-06 (7)